Alberta Investment Management Corp Organogenesis Holdings Inc. Transaction History

Alberta Investment Management Corp

  • $10.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.9 - $4.3 $51,533 - $116,628
27,123 Added 45.86%
86,264 $286,000
Q4 2022

Feb 14, 2023
BUY
$2.48 - $3.43 $146,669 - $202,853
59,141 New
59,141 $159,000
Q2 2022

Aug 15, 2022
SELL
$4.74 - $8.15 $116,902 - $201,003
-24,663 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$6.47 - $9.57 $159,569 - $236,024
24,663 New
24,663 $188,000

Others Institutions Holding ORGO

# of Institutions
118
Shares Held
64.3M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $437M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email